BioMelbourne Network
Progressing BioIndustry
News and Opinions
2012
February
Marketing approval granted for Ellavie in Switzerland
1 February 2012Acrux (ASX: ACR) announced today that Swissmedic, the Swiss agency for therapeutic products, has granted a marketing authorisation in Switzerland for Ellavie™, Acrux’s estradiol spray for treating menopause symptoms. Acrux’s estradiol spray is approved for marketing in the United States and Sweden, with marketing applications under review by regulatory authorities in South K... read more…
Immuron & Monash University to Develop a Clostridium difficile Therapeutic
1 February 2012Australian biopharmaceutical company Immuron Limited (ASX: IMC), manufacturer of Travelan®, has entered into a collaboration agreement with Monash University to develop a product or products that will be aimed at both prevention and treatment of Clostridium difficile (C. difficile) infections. The therapeutic will be based on Immuron’s hyper-immune colostrum platform technolog... read more…
Research collaboration creates 15 new jobs for Victoria
1 February 2012Minister for Technology Gordon Rich-Phillips today welcomed a partnership between The Monash Institute of Pharmaceutical Sciences, Monash University (MIPS) and a leading European pharmaceutical company Les Laboratoires Servier (Servier) to undertake cutting-edge drug discovery and research activities in Victoria.Mr Rich-Phillips said the collaboration with Servier reinforced... read more…
January
AdAlta and Roche sign agreement to evaluate shark antibody technology
AdAlta and Roche sign agreement to evaluate shark antibody technology
Melbourne, Australia, 9th January 2012 – AdAlta Pty Ltd (AdAlta), a Melbourne based biotechnology company specialising in the discovery and development of protein based therapeutics, signed an agreement today with international pharma company, Roche to evaluate and identify shark antibody binders.
"We are excited ab... read more…
2011
December
$114.2 million investment in health and medical research
19th December 2011: Some of the best and brightest minds in Australian health and medical research were recognised in Sydney today.Minister for Health Tanya Plibersek has announced that a further $114.2 million investment in health and medical research for 159 grants.“The Gillard Government is proud to be supporting our health and medical research innovators as they develop their products and t... read more…
HealthLinx to finalise patient recruitment for OvPlex™ second trial early due to excellent interim results
16 December 2011, Melbourne: HealthLinx Limited (ASX:HTX) expects to finalise patient recruitment for its second multi-centre, multi-national OvPlex™ biomarker trial by the end of the first quarter 2012 due to excellent interim results from parts one and two of the trial already analysed.
Data analysed to date are derived from
a sample set comprising 222 women with malignant e... read more…
Dr Phil Kearney, MSD, elected to the board of the BioMelbourne Network
16 December 2011. Dr Phil Kearney, Director-Licensing & External Research, Merck Sharp & Dohme has been elected to the Board of the BioMelbourne Network today as a Nominated Member.
The Board of the BioMelbourne Network and the management group warmly welcomed Dr Kearney to the organsiation at the December board meeting. Dr Kearney has represented Merck Sharp and Dohme as a member of the ... read more…
Genetic Technologies Appoints Dr. Mel Bridges as Chairman
December 16th, 2011.
The Board of Directors of Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) has with great pleasure appointed Dr. Mel Bridges as Chairman and non-executive Director of the Company.
Mel Bridges has over 30 years’ experience in the diagnostic and healthcare industries. During this period, Mel has founded and managed successful diagnostics, therapeutics and med... read more…
New Federal Minister for Industry and Innovation
12 December 2011. Today I announce changes to the Ministry and the Cabinet. These changes will better equip the Government to focus on its priorities for the coming year:
Keeping the economy strong and ensuring Australians have jobs as the economy goes through a period of profound transformation.
Using our prosperity to spread benefits to all Australians.
The Australian economy and Austr... read more…
Government to Improve Regulation of Therapeutic Goods
8 December 2011. The Gillard government will introduce a comprehensive package of reforms for Australia’s Therapeutic Goods Administration (TGA) to ensure the regulation of medicines and medical devices is more effective and transparent.
Releasing TGA reforms: A blueprint for TGA’s future, the Parliamentary Secretary for Health and Ageing, Catherine King, said that several important review... read more…
